(Q45164398)

10 December 2017

title

Sumatriptan (5-HT1B/1D-agonist) causes a transient allodynia (English)

1 reference

10 December 2017

Linde M

1

1 reference

10 December 2017

Elam M

2

1 reference

10 December 2017

Lundblad L

3

1 reference

10 December 2017

Olausson H

4

1 reference

10 December 2017

Dahlöf CG

5

1 reference

10 December 2017

language of work or name

English

0 references

publication date

1 December 2004

1 reference

10 December 2017

1 reference

10 December 2017

volume

24

1 reference

10 December 2017

issue

12

1 reference

10 December 2017

page(s)

1057-1066

1 reference

Observations on 500 cases of migraine and allied vascular headache

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Deconstructing migraine headache into peripheral and central sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Some clinical features of the acute migraine attack. An analysis of 750 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Adverse reactions attributed to sumatriptan. A postmarketing study in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

The site of common side effects of sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Impact of chest pain on cost of migraine treatment with almotriptan and sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Activation of Pain by Sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Method for quantitative estimation of thermal thresholds in patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

What decline in pain intensity is meaningful to patients with acute pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

A comparison of two methods for measuring thermal thresholds in diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Quantitative somatosensory thermotest. A key method for functional evaluation of small calibre afferent channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Peripheral and central mechanisms of cutaneous hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

The peripheral apparatus of muscle pain: evidence from animal and human studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Effects of inflammatory mediators on gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Mediation of serotonin hyperalgesia by the cAMP second messenger system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Serotonin is a directly-acting hyperalgesic agent in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Interaction of 5-HT1B/D ligands with recombinant h 5-HT1A receptors: intrinsic activity and modulation by G-protein activation state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Functional imaging of an illusion of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Dynamic mechanical allodynia in humans is not mediated by a central presynaptic interaction of A beta-mechanoreceptive and nociceptive C-afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Functional imaging of brain responses to pain. A review and meta-analysis (2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Central pain in a hemispherectomized patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Characterization of the glutamatergic system for induction and maintenance of allodynia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

Effects of the anti-migraine drug sumatriptan on muscle energy metabolism: relationship to side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-2982.2004.00782.X

10.1111/J.1468-2982.2004.00782.X

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference